Dr Reddy's Labs launches generic version of Allegra in US

Drugmaker, Dr Reddy's Laboratories Ltd., has announced the first-to-market launch of over-the-counter (OTC) Fexofenadine HCl 180 mg and Pseudoephedrine HCl 240 mg Extended Release Tablets, USP, the store-brand equivalent of Allegra-D 24 HR in the U.S. market, as approved by the U.S. Food and Drug Administration (USFDA).

"The launch of Dr Reddy's Fexofenadine HCl 180 mg and Pseudoephedrine HCl 240 mg Extended Release Tablets, USP, is an important addition to our upper respiratory portfolio of OTC products," says Marc Kikuchi, CEO, North America Generics, Dr. Reddy's Laboratories. "This first-to-market launch is a testament to our deep capabilities and our continued efforts to bring high quality, affordable store-brand alternatives for our customers and patients."

For more details, check out the full story on the link below:

Dr Reddy's Labs Unveils Generic Version Of Allegra In US